Login

A billion dollar company in her early twenties|Lucy Guo,Founder and General Partner,Scale 00:10:00

Share On Facebook Share On Twitter

Co-founder of Scale AI, currently worth $7.3B.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Behind the Bell: Principal Asset Management|Kamal Bhatia,Head of Asset Management,Principal Financial
00:10:00
Investors Demand Evidence Behind IPO Valuations, Says Partners Group's Layton | Dave Layton, CEO, Partners Group.
00:10:00
John Clifford is the Chairman of Gentrack.
00:10:00
This episode explores growth opportunities, sustainability highlights, and the market outlook for growth equity investments in alternative assets.
00:10:00
Sarama Resources' Strategic Plans and Investment Potential in 2020: Insights from the CEO at Cape Town Mining Conference
00:10:00
Software AG CEO Sanjay Brahmawar and Persistent CEO Sandeep Kalra discuss key client priorities.
00:10:00
Joymode is enabling rental commerce for the good of consumers and the planet|Al Sambar,General Partner,XRC Labs
00:10:00
Excelsior Gold: Unlocking Potential at the Galena North Project
00:10:00
"Unlocking Real Assets for Retail Investors: Insights from Dale Holmes of Spire Capital | Dale Holmes - Investment Strategist, Spire Capital"
00:10:00
Navigating Leadership and Innovation: A Conversation with Angi CEO Oisin Hanrahan | Oisin Hanrahan, CEO, Angi Inc.
00:10:00
Exploring Greenland's Gold Potential: The Mamluk Altman Project
00:10:00
A Partnership in Finance: The Lenity Financial Origin Story | Sarah and Michael Anderson, Co-Founders, Lenity Financial, Inc.

© 2026 Nehu